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Abstract: Cycle inhibiting factors (Cifs) are type III secreted effectors produced by diverse 
pathogenic bacteria. Cifs are “cyclomodulins” that inhibit the eukaryotic host cell cycle 
and also hijack other key cellular processes such as those controlling the actin network and 
apoptosis. This review summarizes current knowledge on Cif since its first characterization 
in enteropathogenic Escherichia coli, the identification of several xenologues in distant 
pathogenic bacteria, to its structure elucidation and the recent deciphering of its mode of 
action. Cif impairs the host ubiquitin proteasome system through deamidation of ubiquitin 
or the ubiquitin-like protein NEDD8 that regulates Cullin-Ring-ubiquitin Ligase (CRL) 
complexes. The hijacking of the ubiquitin-dependent degradation pathway of host cells 
results  in  the  modulation  of  various  cellular  functions  such  as  epithelium  renewal, 
apoptosis and immune response. Cif is therefore a powerful weapon in the continuous arm 
race that characterizes host-bacteria interactions. 
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1. Discovery and Distribution of the Cycle Inhibiting Factors (Cifs) That Triggers an Original 
Cytopathic Effect in Host Cells 
The effect of Cif was first observed in 1997 by De Rycke et al. in HeLa cells transiently infected 
with enteropathogenic Escherichia coli (EPEC) strains isolated from weaning rabbits or human infants 
with diarrhea [1]. This so-called cytopathic effect (CPE) was first characterized by the progressive 
formation  of  actin  stress  fibers  together  with  focal  adhesions,  and  a  dramatic  cell  enlargement  
(Figure 1). It was further shown that these large cells were irreversibly impaired for cell proliferation, 
with  a  complete  lack  of  mitotic  figures  [2]  (Figure  1).  This  effect  is  dependent  on  the  locus  of 
enterocyte effacement (LEE), the cluster of genes responsible for the attaching and effacing lesion, the 
hallmark of EPEC and enterohemorraghic E. coli (EHEC) infection [3,4]. The protein responsible for 
the CPE identified by Marches et al. was called Cif (cycle inhibiting factor). The gene coding for Cif is 
located outside the LEE, on a lambdoid prophage [5].  
Figure 1. Cycle inhibiting factor (Cif) induces cell enlargement, actin stress fibers and 
proliferation  arrest.  HeLa  cells  were  infected  with  enteropathogenic  Escherichia  coli 
(EPEC) producing Cif (left panel) or Cif mutant EPEC (right panel). F-actin is stained with 
phalloidin (red) and DNA is stained with DAPI (blue). Arrows indicate mitotic/dividing 
cells. Bars represent 20 µM. 
 
Two  epidemiological  studies  showed  that  60  to  70%  of  EPEC  and  EHEC  strains  are  
cif-positive [6,7]. However, in one of these studies, it was shown that two thirds of these cif-positive E. 
coli strains do not induce a typical CPE due to frameshift mutations or insertion of an IS element in the 
cif gene. Strikingly, cif is always found as a pseudogene in EHEC strains; this could be due to the 
small size of the strain collection, or could suggest an evolutionary counter-selection of functional Cif 
in Shiga-like producing EHEC strains [6]. Nonetheless, plasmid-mediated expression of wild type Cif 
in EHEC confers the CPE phenotype [5]. 
The E. coli Cif protein is 282 amino-acids long, showing no similarity with any protein except 
several  homologues  in  the  human  pathogens  Yersinia  pseudotuberculosis  (56%  of  identity)  and  
beta-proteobacterium  Burkholderia  pseudomallei  (26%).  Cif  homologues  are  also  found  in  the 
entomopathogens Photorhabdus luminescens (23%) and Photorhabdus asymbiotica (26%). The Cif 
proteins are thus named CifEc, CifYp, CifBp, CifPl and CifPa respectively. In all these bacteria the cif 
genes  are  located  in  prophage  or  prophage-like  region  (Escherichia  and  Photorhabdus  species), 
bordered  by  two  vestigial  transposase  genes  (Burkholderia)  and  in  a  locus  frequently  rearranged 
nearby the yrs region homologous to a recombination target of bacteriophages (Yersinia) [8]. Thus  Toxins 2011, 3                               
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Cif-encoding regions are found in DNA domains prone to rearrangement, suggesting that the cif genes 
were acquired by horizontal gene transfer. Consistent with this hypothesis, the Cif-producing EPEC 
strain E22 was shown to produce cif-carrying infectious phage particles supporting that the cif gene 
was disseminated by horizontal gene transfer among EPEC and enterohemorrhagic (EHEC) strains, as 
shown for other non LEE-encoded effectors [6,9,10]. 
Analysis of the Cif xenologues showed that they are all functional as they reproduced the typical 
CifEc-associated  CPE  when  transfected  into  HeLa  cells,  or  lipofected  following  purification  [8]. 
Importantly,  CifPl  was  shown  to  be  expressed  in  vivo  in  an  insect  model,  the  natural  host  of 
Photorhabdus,  and  reproduced  the  CPE  in  the  non-mammalian  insect  Sf9  cell  line  in  vitro  [11]. 
Similarly, CifBp is also active in vitro when strains of E. coli (EPEC) or Burkholderia thailandensis are 
transformed with a plasmid coding for CifBp and used to infect mammalian cell lines [8,12]. Such 
conservation of an effector function among very distant pathogens belonging to -protobacteria and  
-protobacteria that infect invertebrate and mammal hosts is unique and remarkable. It also supports 
the role of Cifs as virulence factors and could reveal an original strategy of pathogenesis. However, 
Photorhabdus spp. are symbiotic of the nematode vector Heterorhabditis (that releases the bacteria 
into the insect) suggesting that Cif might also act as a fitness or symbiotic factor in the nematode host. 
2. Cif Proteins are Type III Effectors That Traffic to the Nucleus of the Host Cells 
Initial experiments showed that the CPE triggered by cif-positive EPEC strains was dependent on 
the type III secretion system (T3SS) encoded by the LEE as mutants of the secretion and translocation 
apparatus (EscN and EspA, EspB, EspD, respectively) were unable to induce the CPE [1,2,5,13]. This 
T3SS injects an arsenal of effector proteins into the host cell that hijack cellular functions for the 
pathogen’s benefit [3,4,14]. Using a reporter system based on a translational fusion of the effector 
protein with β-lactamase that allows detection of translocation in living host cells, Charpentier and 
Oswald showed that an exchangeable N-terminal translocation signal comprising the first 16 amino 
acids of CifEc is necessary and sufficient to mediate its translocation by the EPEC T3SS [15]. Using a 
lipid-based cell delivery system bypassing T3SS requirement, purified CifEc induced a CPE similar to 
that observed upon EPEC infection. This result indicated that CifEc is necessary and sufficient and does 
not  require  other  bacterial  molecules  to  induce  the  CPE  [16].  Once  injected  into  the  host  cell 
cytoplasm by the T3SS, CifEc is rapidly sorted to the peri-nuclear area and the nucleus, as observed by 
confocal imaging and cell fractionation [17]. As CifEc lacks classical nuclear localization sequences, 
the mechanism of nuclear targeting of Cif remains to be elucidated. 
While  CifBp  has  been  shown  to  be  injected  by  the  T3SS  of  Escherichia  and  Burkholderia  
species and successfully reproduces the CPE [8,12], we and other have been unable to translocate CifYp 
and CifPl by the E. coli T3SS into the host cells. However, we have indirect evidence that they are 
bona fide type 3 effectors as both Yersinia and Photorabdhus strains possess T3SS. Moreover, none of 
the Cifs could induce the CPE without electroporation, transfection or lipofection suggesting that Cif 
activity depends on its injection into the host cell [8,11,16].  Toxins 2011, 3                               
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3. Crystal Structure Studies of Cif Homologs Reveals a Family of Proteins Sharing a Conserved 
Active Site 
Despite  a  low  level  of  sequence  similarity  between  Cif  homologs,  the  crystal  structure 
determination  of  CifEc,  CifPl and  CifBp  showed  that  these  proteins  are  structurally  well-conserved 
(Figure 2) [18–20]. The overall structure of these Cif can be divided in two lobes with head and tail 
domains where the N-terminal part corresponds to the tail and contains the potential substrate binding 
site (see below) whereas the C-terminal part forms the head domain hosting the enzymatic site. The 
enzymatic site consists in a catalytic triad composed of residues Cys, His and Gln strictly conserved in 
all Cifs homologs (Figure 2). 
Figure 2. Cif homolog proteins are structurally related and share a conserved catalytic site. 
CifPl, CifBp and CifEc are represented as composites of ribbon and surface plot diagrams. 
Note that the crystallized CifEc protein lacked 99 amino acids in its N-terminal part. The 
side chains of the critical residues of the catalytic triad (Cys, His, Gln) are shown. The  
α-helices α4 and α5 of CifBp are indicated. The right panel represents a superimposition of 
the three Cifs magnified at the level of the catalytic pocket. 
 
The conserved catalytic triad is located in a negative charged cleft with a putative occluding loop 
near the active site that might control the substrate accessibility to the catalytic site [19]. The structural 
organization of this triad reveals that Cifs are divergent members of the superfamily of enzymes that 
comprises papain-like cysteine proteases, acetyl transferases, deamidases and transglutaminases. In 
particular, Cif shares homology with the avirulence effector AvrPphB from Pseudomonas syringae 
that belongs to the same superfamily and with the cysteine protease YopT from Yersinia spp. [19]. 
Mutation of one of the residues of the catalytic triad abolishes CifPl, CifBp, CifEc and CifYp activity, 
corroborating the implication of an enzymatic-dependent activity [8,16,19,20]. Further analysis of the 
tail  domain  showed  that  deletion  of  the  N-terminal  protruding  α4  and  α5  helix  of  CifBp  
(Figure 2) and of the corresponding 4 domain of CifEc suppressed the toxin activity suggesting that 
this domain could mediate substrate recognition [17,20]. 
Based  on  the  structure  and  function  conservation,  Cif  homologs  constitute  a  family  of 
cyclomodulins that likely target a molecule/pathway conserved in a wide range of eukaryotic cells 
from invertebrates to mammals [8,21]. Toxins 2011, 3                               
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4. Cifs Are Cyclomodulins That Trigger Host Cell Cycle Arrest 
Upon injection into host cells by the T3SS (or by transfection or lipofection of purified proteins) Cif 
proteins induce an irreversible cell cycle arrest with complete inhibition of mitotis entry (Figure 1: 
absence of mitotic figures in cells injected with Cif). This property makes Cifs as members of the 
cyclomodulin family defined as bacterial molecules that hijack host cell cycle functions [22,23]. 
The cell cycle arrest induced by CifEc is associated to the inhibitory phosphorylation of the cyclin 
dependent kinase (CDK) 1-CyclinB complex whose activation is necessary for the cell cycle G2/M 
transition [1,2,5]. Other cyclomodulins, such as CDT or Colibactin, also block the G2/M transition 
through inhibition of CDK1 activity. However, in contrast to CDT and Colibactin, which have been 
shown to be bona fide genotoxins, CifEc does not induce DNA damage nor activate the DNA damage 
response  pathway  (ATM/ATR,  CHK1/2,  CDC25  sequestration)  that  leads  to  the  inhibitory 
phosphorylation of CDK1 [16]. Therefore, CifEc induces the cell cycle arrest by activating a pathway 
independent from the canonical activation of the G2/M checkpoint. Further studies, using synchronized 
cells, have shown that CifEc also blocks S-phase entry. Depending on the stage of the cell cycle during 
infection with cif-positive EPEC, cells arrest either at the G1/S or G2/M transition. The analysis of host 
cell proteins regulating both S- and M- phases entries demonstrated a Cif-dependent accumulation of 
p21
Waf1/Cip1 and p27
kip2 (hereafter called p21 and p27)  [24]. These proteins belong to the Cip/Kip 
family of CDK inhibitors (CKI). p21 is an inhibitor of the CDK1/CyclinB complex. This complex is 
the eukaryotic universal inducer of mitosis entry and p21 accumulation is known to inhibit G2/M 
transition.  Both  p21  and  p27  inhibit  CDK2-CyclinE  and  A  complexes  whose  activation  are  also 
required for G1/S and S-phase progression. p21 also binds to PCNA, and the latter is required for  
S-phase  progression  [25].  Therefore,  Cif-dependent  accumulation  of  CKI  is  consistent  with  the 
observed  G1/S  and  G2/M  cell  cycle  arrests  (Figure  3).  The  inhibitory  phosphorylation  of  CDK1 
observed upon CifEc injection could be explained by the disruption of the CDK1 positive feed-back 
loop  leading  to  CDK1  dephosphorylation  via  CDC25.  Further  investigation  revealed  that  CKI 
accumulation does not depend on transcriptional activation but relies on their stabilization in infected 
cells [24]. Since p21 and p27 are degraded by the ubiquitin-proteasome system, these results strongly 
suggested  that  CifEc  controls  this  proteolytic  pathway.  However,  suppression  of  p21  and/or  p27 
accumulation  did  not  alleviate  Cif-induced  inhibition  of  G1/S  or  G2/M  transitions  implying  an 
alternative mechanism for blockage of the cell cycle [24]. Whether this arrest is associated to stress 
fibers  induction  was  excluded  since  disruption  of  stress  fiber  formation  in  HeLa  cells  by  C3 
exoenzyme-mediated inhibition of RhoA, did not alleviate cell cycle inhibition [2]. Morevover, only 
HeLa and RK13 cells exhibit stress fibers following cif
+ EPEC infection suggesting that these two 
phenotypes  are  not  related  [16].  Nonetheless,  these  results  indicated  that  accumulation  of  CKI 
participates in a multi-step process leading to the Cif-induced arrest of cell proliferation.  
This cell cycle inhibition and CKI accumulation was observed with all Cif homologues [8] and in 
various cell lines derived from colonic epithelium (differentiated or not differentiated Caco-2 cells, 
DLD1, HCT116 wild-type, p21
−/− or p53
−/−) showing the independency of cell-cycle arrest from the 
p53  transcriptional  program  [16,24].  The  Cif-induced  cystostatic  effect  is  also  observed  in  
non-transformed IEC-6 cells derived from rat intestinal crypt epithelium. However, the outcome of this 
arrest is cell type dependent as it persists for more than 3 days in HeLa cells without evident cell death, Toxins 2011, 3                               
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whereas it culminates in apoptosis 48 h after infection of IEC-6 cells [26]. Whether this Cif-induced 
cell death is a consequence of the cytostatic effect or relies on an independent pathway is still unclear, 
but it is tempting to propose that the functionality of p53 pathway, intact in non-transformed cells, 
might be decisive for the fate of Cif-arrested cells.  
5. Cif Effector  Proteins  Target NEDD8 to Inhibit Specific Ubiquitin-Dependent Degradation 
Pathways 
Three  independent  teams  recently  deciphered  the  molecular  mode  of  action  of  CifEc  and  
CifBp  [12,17,27].  Despite  few  differences  mainly  related  to  the  species  origin  of  Cif  and  diverse 
approaches,  these  complementary  studies  showed  a  common  mechanism  of  action  between  
the two xenologs. 
Figure 3. Cif inhibits host cell cycle progression. Cif induces the accumulation of p21 and 
p27  that  inhibits  CDK1-CyclinB  and  CDK2-CyclinA/E.  Since  these  complexes  are 
responsible for G2/M and G1/S transitions, Cif provokes an accumulation of cells arrested 
in G1 and G2 phases of the cell cycle. 
 
5.1. CifEc Interacts with Host Protein NEDD8 
As mentioned earlier, Cif-dependent accumulation of p21 and p27 results from the inhibition of 
their degradation by the ubiquitin-proteasome system [28]. Ubiquitylation is a well-known and highly 
controlled post-translational protein modification that involves three successive steps. First, ubiquitin 
is processed by the ubiquitin activating enzyme (E1) and then transferred to the ubiquitin conjugating 
enzyme  (E2).  The  last  step  requires  the  ubiquitin  ligase  (E3)  that  determines  the  substrate  to  be 
ubiquitylated and promotes a direct transfer of ubiquitin from E2 to the substrate (RING-type E3s) or 
an indirect transfer via formation of an ubiquitin thioester-bound E3 prior ubiquitin transfer to the 
substrate (HECT-type E3s). Repetitions of this cycle lead to the attachment of a polyubiquitin chain to 
the target protein, resulting in modulation of its function or localization, or its sorting for degradation, 
depending  on  the  length  and  the  type  of  linkage  within  the  polyubiquitin  chain  [29–31].  Yeast  
two-hybrid screens and pull-down assays showed that CifEc interacts with the ubiquitin-like protein 
NEDD8 [17,27]. The main known role of NEDD8 is the conjugation of the cullin subunit of the 
complex cullin-RING E3 ubiquitin ligase (CRL) and activation of its ligase activity [32–34]. CRL are Toxins 2011, 3                               
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composed of the scaffold protein cullin (at least five different cullins CUL1/2/3/4A/4B are known), the 
RING protein that associates with E2, and different substrate recognition modules that bind the target 
protein (Figure 4) [35,36]. Inactivation of CifEc by mutation of the catalytic cysteine increased its 
binding to NEDD8 [17]. In contrast, deletion of the  4 domain of CifEc, which results in loss of 
activity, abolished the interaction with NEDD8 implying the role of this domain to mediate Cif effect. 
CifEc was unable to pull-down ubiquitin showing the specificity of interaction with NEDD8. Moreover, 
NEDD8  co-compartmentalizes  with  CifEc  in  the  nuclei  of  infected  cells  supporting  the  functional 
binding of these 2 proteins [17]. Co-immunoprecipitation experiments showed that CifEc interacts only 
with the neddylated forms of cullins (CUL1 to 4B) associated with the RING protein [17] and with the 
recognition module Skp1 and Skp2 proteins [27]. It thus appeared that CifEc interacts with the whole 
CRL complex through binding to NEDD8 (Figure 4). 
Figure 4. Model of CifEc inhibition of CRL activation cycle. Neddylated active CRL (left) 
ubiquitylates the substrate (sub) and substrate recognition module (SRM) leading to their 
degradation  and  generating  inactive  CRL  (top).  Deneddylation  of  CRL  by  the  COP9 
signalosome allows binding of CAND1 (right). SRM fixation induces CAND1 release and 
subsequent neddylation of cullin to generate an active CRL [35,36]. Cif binding to and 
deamidation of NEDD8 impairs the action of COP9, blocking the activation cycle and 
locking the CRL in an inactive neddylated state. 
 
5.2. Cif Inhibits CRL Activity 
Since Cif proteins induce the stabilization of p21 and p27, which are substrates of CRL associated 
to  CUL1,  in  vitro  studies  were  conducted  to  investigate  the  inhibitory  effect  of  Cif  on  CRL.  
Jubelin  et  al.  showed  that  addition  of  CifEc  to  reconstituted  CRL  inhibited  its  ubiquitin  ligase 
activity [17]. Moreover, in cellulo ubiquitylation of various CRL substrates such as p27 or RhoA was 
severely  impaired  by  CifEc  and  CifBp,  respectively  [12,27].  Stabilization  of  various  CUL1  to  
4B-associated CRL substrates including β-catenin, RhoA, IBα, Cdt1, CyclinD1 reveals that CifEc can 
interfere with all neddylated cullins [17,27]. Toxins 2011, 3                               
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How CifEc inhibits CRL activity is not fully elucidated. However, Cui et al. showed that the CRL 
inhibition  is  associated  to  CifEc-dependent  NEDD8  deamidation  of  Gln40,  converting  glutamine 
residue in glutamic acid (Glu). Replacement of NEDD8 with deaminated NEDD8 (NEDD8Q40E) 
abolished the in vitro stimulatory effect on Nrf2 ubiquitylation by a CUL3/ROC1/Keap1 complex. 
Similarly,  ectopic  expression  of  NEDD8Q40E  in  HeLa  cells  resulted  in  the  stabilization  of  CRL 
substrate and recapitulated the effects of Cif [12]. On the other hand, CifEc was shown to promote 
cullin neddylation of CUL1 to 4B [17] that correlates with the inhibition of deneddylation of cullin by 
the CSN complex (COP9 signalosome) [27]. This phenotype is similar to the effect observed using 
CSN5 null cells that also accumulate CRL substrates such as p27 [37]. Together, these results suggest 
that modification of NEDD8 by Cif inhibits cullin deneddylation by the CSN resulting in a decrease of 
CRL activation. Indeed, to be fully active, CRLs undergo an activation cycle in which cullins oscillate 
between neddylated and non-neddylated states [35,36]. Based on these results, we propose a model in 
which CifEc interferes with this cycle and thus locks CRLs in a neddylated but inactive state (Figure 4). 
A notable difference between CifBp and CifEc is the capacity of CifBp to deamidate not only NEDD8, 
but also the Gln40 of ubiquitin. CifBp generates an E2-ubiquitinQ40E thioester complex that impairs 
ubiquitin chain synthesis and the ubiquitylation pathway in vitro and in vivo [12]. This supplementary 
affinity to ubiquitin extends the inhibitory activity of CifBp to all ubiquitylation process independently 
of the E3 ligase. The relevance of this difference is still unclear and requires further studies on the 
range of action of other Cif homologs and bacterial deamidases toward ubiquitin and ubiquitin-like 
molecules. In this line, it is noteworthy that the Mycobacterium deamidase of Pup (Dop), required for 
the full virulence of M. tuberculosis, targets the prokaryotic ubiquitin-like molecule Pup to convert the 
terminal glutamine residue into glutamate [38,39]. Also, while acting through a different pathway to 
stimulate RhoA activity, it is remarkable that the cyclomodulin CNF-1 directly deamidates RhoA to 
induces actin stress fibers [40,41]. 
6. Concluding remarks and perspectives 
The role of NEDD8 on CRL activation offers to the bacteria injecting Cif into the host cells an 
“Achilles  heel”  to  hijack  various  cellular  signaling  functions.  Indeed,  CRLs  represent  the  largest 
subfamily of E3s and therefore play regulatory roles in numerous and diverse cellular functions. The 
diversity of substrate recognition modules associated to the different cullin subunits gives to the CRL 
the  capacity  to  ubiquitylate  and  thus  to  control  the  stability  of  hundreds  of  proteins  [35,36].  Cif 
capacity  to  induce  stress  fibers  in  certain  eukaryotic  cells  could  be  related  to  Cif-stabilization  of  
RhoA  [12,17],  which  is  targeted  by  CUL3-associated  CRL  [42].  Prevention  of  inappropriate 
replication  depends  on  the  degradation  of  the  licensing  factor  Cdt1  during  S-phase  [43].  As  
CUL4-associated CRL targets  Cdt1  for ubiquitylation-dependent  degradation  [44,45], inhibition of 
CRL  by  Cif  provides  a  satisfactory  explanation  for  occurrence  of  re-replication  observed  3  days 
following infection as Cdt1 is stabilized in infected HeLa cells [2,16,17]. Moreover, Cif was shown to 
prevent  the  degradation  of  IB,  a  central  inhibitor  of  NF-B  pro-inflammatory  response  [12,17]. 
Down-regulation of the NF-B pathway has been proposed to mediate the inflammatory tolerance of 
commensal  bacteria  in  the  mammalian  intestinal  epithelia  [46,47].  In  addition,  stabilization  of  
β-catenin by Cif might participate in dendritic cells tolerogenicity as it was recently shown that the 
WNT signaling pathway regulates immunosuppressive responses [48].  Toxins 2011, 3                               
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In conclusion, Cif might represent a fitness factor that facilitates bacterial evasion from the host 
immune response, via inhibition of inflammatory pathways in dendritic cells of the gut-associated 
lymphoid tissue. Cif-inhibition of the host cell cycle might slow down multiplication of intestinal 
progenitors to delay epithelial cells renewal, thus favoring gut colonization (Figure 5). We could also 
speculate about the role of Cif as a stabilizer of other type III co-injected effectors, to modulate their 
effect on host cells and boost the virulence of cif-expressing strains. Further studies of the impact of 
Cif  in  the  pathogen-host  interactions  will  undoubtedly  contribute  to  our  knowledge  of  bacterial 
pathogenic strategies. It also appears that the continuous “arm race” that characterizes host-pathogen 
relationship has lead the bacteria to develop sophisticated “weapons” (virulence factors) capable of 
controlling host’s functions for their own benefit. Therefore, much can be learned from eukaryotic 
functions using bacterial toxins such as Cif. While most pharmacological inhibitors or bacterial/viral 
proteins inhibit CRL by decreasing cullin neddylation [49–52], Cif is the first example of a bacterial 
effector that inhibits CRL functions by stabilizing cullin neddylation. Thus Cif represents a unique tool 
to study the regulation of the ubiquitin proteasome system. Lately, it was reported that inhibitors of 
NEDD8 represent a promising approach for cancer treatment [52] opening a potential development of 
innovative therapeutics using Cif-producing bacteria. 
Figure 5. Cif hijacks several and various signaling pathways by inhibiting the ubiquitin 
ligase activity of CRL. Cif is injected in the host cells and impairs CRL activity via binding 
to NEDD8. This inhibition results in stabilization of (i) p21 and p27 leading to cell cycle 
inhibition; (ii) Cdt1 allowing inappropriate replication; (iii) RhoA inducing actin stress 
fibers; (iv) IkB leading to alteration of inflammatory response; (v) β-catenin promoting 
differentiation  process  disruption  and  tolerogenicity;  (vi)  unidentified  protein(s)  
inducing apoptosis. 
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